There were 123 press releases posted in the last 24 hours and 228,474 in the last 365 days.
Rising occurrences of target conditions and advancements in biomedical technology are among the significant factors influencing market revenue growth
VANCOUER, BC, CANADA, August 29, 2022 /EINPresswire.com/ -- The global biologics market is projected to reach USD 567.96 Billion in 2028 at a steady revenue CAGR of 8.4% over the forecast period, according to latest analysis by Emergen Research. Some key factors attributed to steady market revenue growth include rising demand for monoclonal antibodies, recombinant hormones/proteins, gene-based & cellular-based biologics, vaccines, and molecular therapy, etc. in the treatment of diseases including cancer, infectious diseases, immunological diseases, cardiovascular diseases, and hematological diseases, among others. Also, rising use of biologics for the treatment of autoimmune diseases, comprising various arthritis types, including ankylosing spondylitis, rheumatoid arthritis, and psoriatic arthritis, is playing a crucial role in driving revenue growth of the global biologics market.
The Global Biologics Market Research Report provides a brief overview inclusive of the competitive landscape and key developments, policies, manufacturing costs, and processes. The report also provides the analysis of import/export, production and consumption ratio, supply and demand, cost, price, estimated revenue, and gross margins. The report further discusses in detail the driving factors influencing the growth of the market currently and in the coming years.
๐ ๐จ๐ซ ๐๐ซ๐ข๐ญ๐ข๐๐๐ฅ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ, ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐๐ญ @ https://www.emergenresearch.com/request-sample/61
Surging demand and higher adoption of novel biologics drugs and therapies across the globe for the treatment of disease conditions is a significant factor causative of steady market revenue growth. One such novel drug is Antibody-Drug Conjugate (ADC), which is a highly effective drug used in disease treatment. In cancer treatment, ADC delivers drugs to the disease/target cells with a very high specificity, thereby maximizing efficacy and lessening systemic exposure, as well as associated side effect risks. Based on payload attached to the antibody, ADC can be deployed to influence several biological functions.
What is the projected growth rate likely to be witnessed by each market region? Which of the leading Biologics Market regions accounts for the maximum market share over the forecast years? What sales estimates every region is expected to hold in the Biologics Market in the near future? What is each regional segmentโs current valuation? What are the estimated remunerations of these regions over the forecast timeline?
In September 2020, Biocon Biologics Ltd. and Mylan made an announcement about the introduction of biosimilar Semglee in the US. This biosimilar is available, both in pre-filled pen and vials, and is intended for controlling high blood pressure in adults having type 2 diabetes and pediatric patients having type 1 diabetes.
Among the source segments, mammalian segment revenue is expected to register a significantly rapid growth rate over forecast period. Expression systems deploying mammalian cells for recombinant hormones/proteins can introduce appropriate protein folding, PTM (post-translational modifications), and product assembly that are essential for overall biological activity.
Among the product type segments, vaccines segment revenue is expected to expand at a relatively faster rate over forecast period. A vaccine functions by preparing the immune system to identify and fight pathogens, either bacteria or viruses. Vaccines are beneficial in reducing preventable infectious diseases, and currently, fewer number individuals suffer from the distressing effects of pertussis and measles, among other illnesses. Presently, vaccines are witnessing spiraling demand across the globe to curb the spread of COVID-19 and resulting mortalities occurring due to the disease.
The market in Asia Pacific is expected to register fastest revenue CAGR over forecast period due to improving healthcare infrastructure, rising investments in biologics development, and better reimbursement scenario in some countries in the region.
๐๐จ ๐ ๐๐ญ ๐๐๐๐๐ฌ๐ฌ ๐ญ๐จ ๐ญ๐ก๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐จ๐ง ๐ญ๐ก๐ ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ , ๐๐ฅ๐ข๐๐ค ๐จ๐ง ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค ๐ฆ๐๐ง๐ญ๐ข๐จ๐ง๐๐ ๐ก๐๐ซ๐: @ https://www.emergenresearch.com/industry-report/biologics-market
The report on the Global Biologics Market initially offers an in-depth overview of the Biologics Market along with insights into the developments and advancements in the sector. The report offers a comprehensive overview of the regional and competitive landscape and provides a deeper insight into the current market scenario and future growth prospects. The research study also provides a complete analysis of the market drivers, restraints, limitations, threats, risks, and growth opportunities.
Novo Nordisk A/S, Pfizer Inc., Amgen, Sanofi, Samsung BioLogics, Merck & Co. Inc., Celltrion, AbbVie Inc., Johnson & Johnson Services Inc., Eli Lilly & Company, F Hoffman La Roche, Addgene, Novartis AG, and GlaxoSmithKline.
The report highlights the latest trends observed in the consumption pattern of each regional segment. Extensive market segmentation included in the report helps better understand the revenue and estimated growth of the individual regions. The report throws light on the historical and current market scenarios and provides a concise year-on-year growth rate of the Biologics Market . The report further entails the current market trends, technological advancements, revenue growth, and other aspects affecting market growth.
To Gain In-Depth Insights on biologics market, click here
๐๐ซ๐จ๐๐ฎ๐๐ญ ๐๐ฒ๐ฉ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง; ๐๐๐๐-๐๐๐๐) Monoclonal Antibodies Vaccines Recombinant Hormones/Proteins Cellular-Based Biologics Gene-Based Biologics Others
๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง; ๐๐๐๐-๐๐๐๐) Cancer Infectious Diseases Immunological Diseases Cardiovascular Diseases Hematological Disorders Others
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ @ https://www.emergenresearch.com/request-for-customization/61
https://www.prnewswire.co.uk/news-releases/battery-recycling-market-size-to-reach-usd-24-57-billion-by-2027-innovative-efforts-to-enhance-the-efficiency-of-the-recycling-process-and-consistent-advancements-in-the-lithium-ion-battery-recycling-are-some-key-factors-driving-industry-gr-883197916.html
https://www.prnewswire.co.uk/news-releases/biologics-market-size-to-reach-usd-477-15-billion-in-2027-rapid-advancements-in-molecular-therapy-and-cell-based-biologics-increasing-incidence-of-chronic-diseases-are-some-key-factors-driving-industry-growth-says-emergen-research-888453573.html
https://www.prnewswire.co.uk/news-releases/esports-market-size-to-reach-usd-5-199-8-million-in-2028-increasing-number-of-live-esports-coverage-platforms-and-participants-and-rising-popularity-of-video-games-are-some-key-factors-driving-industry-demand-says-emergen-research-833994360.html
https://www.prnewswire.co.uk/news-releases/plastic-waste-management-market-size-to-reach-usd-40-80-billion-by-2027-implementation-of-sustainable-development-and-awareness-regarding-hazardous-effects-of-plastic-waste-are-significant-factors-influencing-industry-demand-says-emergen-re-859635859.html
https://www.prnewswire.co.uk/news-releases/mhealth-market-size-to-reach-usd-361-67-billion-in-2027-demand-for-preventive-healthcare-and-rising-investment-to-accelerate-development-of-mhealth-devices-are-some-key-factors-driving-industry-demand-says-emergen-research-875004662.html
Emergen research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help clientโs make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Eric Lee Emergen Research +91 90210 91709 sales@emergenresearch.com Visit us on social media: Facebook Twitter LinkedIn
EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswireโข, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.
ยฉ 1995-2022 Newsmatics Inc. dba EIN Presswire All Right Reserved.